Insulet Corp (PODD)
262.00
-4.58
(-1.72%)
USD |
NASDAQ |
Nov 21, 16:00
262.00
0.00 (0.00%)
After-Hours: 20:00
Insulet Debt to Equity Ratio: 1.251 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 1.251 |
June 30, 2024 | 1.40 |
March 31, 2024 | 1.772 |
December 31, 2023 | 1.932 |
September 30, 2023 | 2.338 |
June 30, 2023 | 2.524 |
March 31, 2023 | 2.778 |
December 31, 2022 | 2.942 |
September 30, 2022 | 3.287 |
June 30, 2022 | 3.342 |
March 31, 2022 | 3.170 |
December 31, 2021 | 2.29 |
September 30, 2021 | 2.583 |
June 30, 2021 | 2.736 |
March 31, 2021 | 1.824 |
December 31, 2020 | 1.755 |
September 30, 2020 | 1.549 |
June 30, 2020 | 1.616 |
March 31, 2020 | 15.24 |
December 31, 2019 | 11.70 |
September 30, 2019 | 6.547 |
June 30, 2019 | 2.432 |
March 31, 2019 | 2.681 |
December 31, 2018 | 2.791 |
September 30, 2018 | 2.953 |
Date | Value |
---|---|
June 30, 2018 | 3.222 |
March 31, 2018 | 3.341 |
December 31, 2017 | 3.572 |
September 30, 2017 | 4.646 |
June 30, 2017 | 5.266 |
March 31, 2017 | 5.296 |
December 31, 2016 | 5.270 |
September 30, 2016 | 5.054 |
June 30, 2016 | 6.402 |
March 31, 2016 | 6.580 |
December 31, 2015 | 5.042 |
September 30, 2015 | 3.154 |
June 30, 2015 | 2.451 |
March 31, 2015 | 2.113 |
December 31, 2014 | 1.957 |
September 30, 2014 | 2.084 |
June 30, 2014 | 2.500 |
March 31, 2014 | 0.9493 |
December 31, 2013 | 0.9121 |
September 30, 2013 | 0.9151 |
June 30, 2013 | 0.7856 |
March 31, 2013 | 0.9334 |
December 31, 2012 | 2.675 |
September 30, 2012 | 2.957 |
June 30, 2012 | 2.371 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.251
Minimum
Sep 2024
15.24
Maximum
Mar 2020
3.401
Average
2.431
Median
Debt to Equity Ratio Benchmarks
Baxter International Inc | 1.643 |
Boston Scientific Corp | 0.5254 |
Abbott Laboratories | 0.3764 |
Globus Medical Inc | 0.1074 |
Bioventus Inc | 2.579 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 3.025B |
Total Liabilities (Quarterly) | 1.907B |
Shareholders Equity (Quarterly) | 1.118B |
Current Ratio | 3.676 |
Net Debt Paydown Yield | -0.00% |